265
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Chronic Obstructive Pulmonary Diseases in Nepal: Evidence from a Nationally Representative Population-Based Study

, ORCID Icon, ORCID Icon, , , , , , ORCID Icon, ORCID Icon, , ORCID Icon, , & show all
Pages 1109-1118 | Published online: 20 Apr 2021

References

  • Global initiative for Chronic Obstructive Pulmonary Diseases. Global strategy for the diagnosis, management and prevention of COPD, 2018. 2018.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • Institute of Health Metrics and Evaluation (IHME). GBD compare data visualization Seattle. WA: IHME, University of Washington; 2017. Available from: https://vizhub.healthdata.org/gbd-compare/. Accessed March 24, 2021.
  • World Health Organization. Chronic obstructive pulmonary diseases, fact sheet. 2013.
  • Worl Health Organization, Control RfIT. WHO report on the global tobacco epidemic, 2008: the MPOWER package: World Health Organization. 2008.
  • Bloom DE, Cafiero E, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging. 2012.
  • Bhandari GP, Angdembe MR, Dhimal M, Neupane S, Bhusal C. State of non-communicable diseases in Nepal. BMC Public Health. 2014;14(1):23. doi:10.1186/1471-2458-14-23
  • Pokharel B, Humagain S, Pant P, Gurung R, Koju R, Bedi T. Spectrum of diseases in a medical ward of a teaching hospital in a developing country. J Coll Med Sci Nepal. 2012;8(2):7–11. doi:10.3126/jcmsn.v8i2.6831
  • Bhandari R, Sharma R. Epidemiology of chronic obstructive pulmonary disease: a descriptive study in the mid-western region of Nepal. Int J Chron Obstruct Pulmon Dis. 2012;7:253. doi:10.2147/COPD.S28602
  • Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global Burden of Disease and Risk Factors. The World Bank; 2006.
  • Karki KB, Dhakal P, Shrestha SL, et al. Situation Analysis of Ambient Air Pollution and Respiratory Health Effects in Kathmandu Valley. Nepal Health Research Council; 2016.
  • Kim BM, Park J-S, Kim S-W, et al. Source apportionment of PM10 mass and particulate carbon in the Kathmandu Valley, Nepal. Atmos Environ. 2015;123:190–199. doi:10.1016/j.atmosenv.2015.10.082
  • Sreeramareddy CT, Ramakrishnareddy N, Kumar HH, Sathian B, Arokiasamy JT. Prevalence, distribution and correlates of tobacco smoking and chewing in Nepal: a secondary data analysis of Nepal Demographic and Health Survey-2006. Subst Abuse Treat Prev Policy. 2011;6(1):33. doi:10.1186/1747-597X-6-33
  • Ministry of Health Nepal NE, ICF. Nepal Demographic and Health Survey 2016. Kathmandu; 2016.
  • Halbert R, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–1692. doi:10.1378/chest.123.5.1684
  • Government of Nepal, National Planning Commision. Nepal’s sustainable development goals, baseline report. 2017.
  • Dhimal M, Karki KB, Sharma SK, et al. Prevalence of selected chronic non-communicable diseases in Nepal. J Nepal Health Res Counc. 2019;17(3):394–401. doi:10.33314/jnhrc.v17i3.2327
  • Nemeth R, editor. Respondent selection within the household-a modification of the Kish grid. Meeting of Young Statisticians. 2002.
  • Stanley AJ, Hasan I, Crockett AJ, Van Schayck OC, Zwar NA. COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24:14024. doi:10.1038/npjpcrm.2014.24
  • Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert R. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6):1531–1539. doi:10.1378/chest.129.6.1531
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Spirometry for health care providers 2010.
  • Soriano JB, Miravitlles M, García-Río F, et al. Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187–193. doi:10.4104/pcrj.2012.00027
  • Ghimire S, Mishra SR, Sharma A, Siweya A, Shrestha N, Adhikari B. Geographic and socio-economic variation in markers of indoor air pollution in Nepal: evidence from nationally-representative data. BMC Public Health. 2019;19(1):195. doi:10.1186/s12889-019-6512-z
  • Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 2004;9(4):458–465. doi:10.1111/j.1440-1843.2004.00637.x
  • El Rhazi K, Nejjari C, BenJelloun M, El Biaze M, Attassi M, Garcia-Larsen V. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: results from the BOLD study. Int J Tuberc Lung Dis. 2016;20(1):136–141. doi:10.5588/ijtld.15.0029
  • Barbara C, Rodrigues F, Dias H, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Revista Portuguesa De Pneumologia. 2013;19(3):96–105. doi:10.1016/j.rppnen.2012.11.001
  • Guerriero M, Caminati M, Viegi G, Senna G, Cesana G, Pomari C. COPD prevalence in a north-eastern Italian general population. Respir Med. 2015;109(8):1040–1047. doi:10.1016/j.rmed.2015.05.009
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
  • Kim DS, Kim YS, Jung K-S, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005;172(7):842–847. doi:10.1164/rccm.200502-259OC
  • Magitta N, Walker RW, Apte KK, et al. Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania. Eur Respir J. 2018;51(2):1700182. doi:10.1183/13993003.00182-2017
  • Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Clemens JD. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD. 2015;12(6):658–667.
  • Lim S, Lam DC-L, Muttalif AR, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14(1):4. doi:10.1186/s12930-015-0020-9
  • Anto J, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982–994. doi:10.1183/09031936.01.17509820
  • Kanervisto M, Vasankari T, Laitinen T, Heliövaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–1146. doi:10.1016/j.rmed.2011.03.008
  • Nepal Go, National Planning Commission CBoS. Environment statistics of Nepal. Kathmandu. 2019.
  • Soler J, Sanchez L, Roman P, Martinez M, Perpina M. Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease. Archivos de Bronconeumología. 2004;40(6):250–258.
  • Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133(2):343–349. doi:10.1378/chest.07-1361
  • Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–939. doi:10.1136/thx.2006.062802
  • Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest. 2005;128(4):2818–2823. doi:10.1378/chest.128.4.2818
  • Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362(9387):847–852. doi:10.1016/S0140-6736(03)14338-3
  • Jarad N. Chronic obstructive pulmonary disease (COPD) and old age? Chron Respir Dis. 2011;8(2):143–151. doi:10.1177/1479972311407218
  • Uzaslan E, Mahboub B, Beji M, et al. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106:S45–S59. doi:10.1016/S0954-6111(12)70014-8
  • Bakke P, Rönmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir Soc. 2011;38:1261–1277. doi:10.1183/09031936.00193809
  • Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483